-
1
-
-
22944462705
-
Defective thrombus formation in mice lacking coagulation factor XII
-
Renné T, Pozgajová M, Grüner S, Schuh K, Pauer HU, Burfeind P, Gailani D, Nieswandt B. Defective thrombus formation in mice lacking coagulation factor XII. J Exp Med 2005; 202: 271.
-
(2005)
J Exp Med
, vol.202
, pp. 271
-
-
Renné, T.1
Pozgajová, M.2
Grüner, S.3
Schuh, K.4
Pauer, H.U.5
Burfeind, P.6
Gailani, D.7
Nieswandt, B.8
-
2
-
-
79959856610
-
Factor XII activation is essential to sustain the procoagulant effects of particulate matter
-
Kilinc E, Oerle RV, Borissoff JI, Kilinç E, van Oerle R, Oschatz C, Gerlofs-Nijland ME, Janssen NA, Cassee FR, Sandström T, Renné T, ten Cate H, Spronk HMH. Factor XII activation is essential to sustain the procoagulant effects of particulate matter. J Thromb Haemost 2011; 9: 1359-67.
-
(2011)
J Thromb Haemost
, vol.9
, pp. 1359-1367
-
-
Kilinc, E.1
Oerle, R.V.2
Borissoff, J.I.3
Kilinç, E.4
van Oerle, R.5
Oschatz, C.6
Gerlofs-Nijland, M.E.7
Janssen, N.A.8
Cassee, F.R.9
Sandström, T.10
Renné, T.11
ten Cate, H.12
Spronk, H.M.H.13
-
3
-
-
77956646450
-
Early atherosclerosis exhibits an enhanced procoagulant state
-
Borissoff JI, Heeneman S, Kilinç E, Kassák P, van Oerle R, Winckers K, Govers-Riemslag JWP, Hamulyák K, Hackeng TM, Daemen MJAP, ten Cate H, Spronk HMH. Early atherosclerosis exhibits an enhanced procoagulant state. Circulation 2010; 122: 821-30.
-
(2010)
Circulation
, vol.122
, pp. 821-830
-
-
Borissoff, J.I.1
Heeneman, S.2
Kilinç, E.3
Kassák, P.4
van Oerle, R.5
Winckers, K.6
Govers-Riemslag, J.W.P.7
Hamulyák, K.8
Hackeng, T.M.9
Daemen, M.J.A.P.10
ten Cate, H.11
Spronk, H.M.H.12
-
4
-
-
80053641885
-
Factor XIIa regulates the structure of the fibrin clot independently of thrombin generation through direct interaction with fibrin
-
Konings J, Govers-Riemslag JWP, Philippou H, Mutch NJ, Borissoff JI, Allan P, Mohan S, Tans G, ten Cate H, Ariëns RAS. Factor XIIa regulates the structure of the fibrin clot independently of thrombin generation through direct interaction with fibrin. Blood 2011; 118: 3942-51.
-
(2011)
Blood
, vol.118
, pp. 3942-3951
-
-
Konings, J.1
Govers-Riemslag, J.W.P.2
Philippou, H.3
Mutch, N.J.4
Borissoff, J.I.5
Allan, P.6
Mohan, S.7
Tans, G.8
ten Cate, H.9
Ariëns, R.A.S.10
-
5
-
-
77950899732
-
Factor XIIa inhibitor recombinant human albumin Infestin-4 abolishes occlusive arterial thrombus formation without affecting bleeding
-
Hagedorn I, Schmidbauer S, Pleines I, Kleinschnitz C, Kronthaler U, Stoll G, Dickneite G, Nieswandt B. Factor XIIa inhibitor recombinant human albumin Infestin-4 abolishes occlusive arterial thrombus formation without affecting bleeding. Circulation 2010; 121: 1510-7.
-
(2010)
Circulation
, vol.121
, pp. 1510-1517
-
-
Hagedorn, I.1
Schmidbauer, S.2
Pleines, I.3
Kleinschnitz, C.4
Kronthaler, U.5
Stoll, G.6
Dickneite, G.7
Nieswandt, B.8
-
6
-
-
34250191847
-
Evidence of a U-shaped association between factor XII activity and overall survival
-
Endler G, Marsik C, Jilma B, Schickbauer T, Quehenberger P, Mannhalter C. Evidence of a U-shaped association between factor XII activity and overall survival. J Thromb Haemost 2007; 5: 1143-8.
-
(2007)
J Thromb Haemost
, vol.5
, pp. 1143-1148
-
-
Endler, G.1
Marsik, C.2
Jilma, B.3
Schickbauer, T.4
Quehenberger, P.5
Mannhalter, C.6
-
7
-
-
4143123359
-
Plasma levels of factor XII, prekallikrein and high molecular weight kininogen in normal blood donors and patients having suffered venous thrombosis
-
Gallimore MJ, Harris SL, Jones DW, Winter M. Plasma levels of factor XII, prekallikrein and high molecular weight kininogen in normal blood donors and patients having suffered venous thrombosis. Thromb Res 2004; 114: 91-6.
-
(2004)
Thromb Res
, vol.114
, pp. 91-96
-
-
Gallimore, M.J.1
Harris, S.L.2
Jones, D.W.3
Winter, M.4
-
8
-
-
33845497457
-
Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: opposite and synergistic effects of factors XI and XII
-
Doggen CJM, Rosendaal FR, Meijers JCM. Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: opposite and synergistic effects of factors XI and XII. Blood 2006; 108: 4045-51.
-
(2006)
Blood
, vol.108
, pp. 4045-4051
-
-
Doggen, C.J.M.1
Rosendaal, F.R.2
Meijers, J.C.M.3
-
9
-
-
40949145685
-
Gene variants associated with deep vein thrombosis
-
Bezemer ID, Bare LA, Doggen CJM, Arellano AR, Tong C, Rowland CM, Catanese J, Young BA, Reitsma PH, Devlin JJ, Rosendaal FR. Gene variants associated with deep vein thrombosis. JAMA 2008; 299: 1306-14.
-
(2008)
JAMA
, vol.299
, pp. 1306-1314
-
-
Bezemer, I.D.1
Bare, L.A.2
Doggen, C.J.M.3
Arellano, A.R.4
Tong, C.5
Rowland, C.M.6
Catanese, J.7
Young, B.A.8
Reitsma, P.H.9
Devlin, J.J.10
Rosendaal, F.R.11
-
10
-
-
70449431510
-
Genetic variants associated with deep vein thrombosis: the F11 locus
-
Li Y, Bezemer ID, Rowland CM, Tong CH, Arellano AR, Catanese JJ, Devlin JJ, Reitsma PH, Bare LA, Rosendaal FR. Genetic variants associated with deep vein thrombosis: the F11 locus. J Thromb Haemost 2009; 7: 1802-8.
-
(2009)
J Thromb Haemost
, vol.7
, pp. 1802-1808
-
-
Li, Y.1
Bezemer, I.D.2
Rowland, C.M.3
Tong, C.H.4
Arellano, A.R.5
Catanese, J.J.6
Devlin, J.J.7
Reitsma, P.H.8
Bare, L.A.9
Rosendaal, F.R.10
-
11
-
-
0034099043
-
High levels of coagulation factor XI as a risk factor for venous thrombosis
-
Meijers JCM, Tekelenburg WLH, Bouma BN, Bertina RM, Rosendaal FR. High levels of coagulation factor XI as a risk factor for venous thrombosis. N Eng J Med 2000; 342: 696-701.
-
(2000)
N Eng J Med
, vol.342
, pp. 696-701
-
-
Meijers, J.C.M.1
Tekelenburg, W.L.H.2
Bouma, B.N.3
Bertina, R.M.4
Rosendaal, F.R.5
-
12
-
-
78349308080
-
Intrinsic coagulation activation and the risk of arterial thrombosis in young women: results from the risk of arterial thrombosis in relation to oral contraceptives (RATIO) case-control study
-
Siegerink B, Govers-Riemslag JWP, Rosendaal FR, Ten Cate H, Algra A. Intrinsic coagulation activation and the risk of arterial thrombosis in young women: results from the risk of arterial thrombosis in relation to oral contraceptives (RATIO) case-control study. Circulation 2010; 122: 1854-61.
-
(2010)
Circulation
, vol.122
, pp. 1854-1861
-
-
Siegerink, B.1
Govers-Riemslag, J.W.P.2
Rosendaal, F.R.3
Ten Cate, H.4
Algra, A.5
-
13
-
-
34548059728
-
The plasma kallikrein-kinin system and risk of cardiovascular disease in men
-
Govers-Riemslag JWP, Smid M, Cooper JA, Bauer KA, Rosenberg RD, Hack CE, Hamulyak K, Spronk HMH, Miller GJ, ten Cate H. The plasma kallikrein-kinin system and risk of cardiovascular disease in men. J Thromb Haemost 2007; 5: 1896-903.
-
(2007)
J Thromb Haemost
, vol.5
, pp. 1896-1903
-
-
Govers-Riemslag, J.W.P.1
Smid, M.2
Cooper, J.A.3
Bauer, K.A.4
Rosenberg, R.D.5
Hack, C.E.6
Hamulyak, K.7
Spronk, H.M.H.8
Miller, G.J.9
ten Cate, H.10
-
14
-
-
0023201944
-
The coagulation-kinin pathway of human plasma
-
Kaplan A, Silverberg M. The coagulation-kinin pathway of human plasma. Blood 1987; 70: 15.
-
(1987)
Blood
, vol.70
, pp. 15
-
-
Kaplan, A.1
Silverberg, M.2
-
15
-
-
67649218762
-
Factor XII-independent cleavage of high-molecular-weight kininogen by prekallikrein and inhibition by C1 inhibitor
-
Joseph K, Tholanikunnel BG, Kaplan AP. Factor XII-independent cleavage of high-molecular-weight kininogen by prekallikrein and inhibition by C1 inhibitor. J Allergy Clin Immunol 2009; 124: 143-9.
-
(2009)
J Allergy Clin Immunol
, vol.124
, pp. 143-149
-
-
Joseph, K.1
Tholanikunnel, B.G.2
Kaplan, A.P.3
-
17
-
-
13444267658
-
Formation of bradykinin: a major contributor to the innate inflammatory response
-
Joseph K, Kaplan AP. Formation of bradykinin: a major contributor to the innate inflammatory response. Adv Immunol 2005; 86: 159-208.
-
(2005)
Adv Immunol
, vol.86
, pp. 159-208
-
-
Joseph, K.1
Kaplan, A.P.2
-
18
-
-
51349160073
-
Misfolded proteins activate Factor XII in humans, leading to kallikrein formation without initiating coagulation
-
Maas C, Govers-Riemslag JWP, Bouma BN, Schiks B, Hazenberg BPC, Lokhorst HM, Hammarström P, ten Cate H, de Groot PG. Misfolded proteins activate Factor XII in humans, leading to kallikrein formation without initiating coagulation. J Clin Invest 2008; 118: 3208.
-
(2008)
J Clin Invest
, vol.118
, pp. 3208
-
-
Maas, C.1
Govers-Riemslag, J.W.P.2
Bouma, B.N.3
Schiks, B.4
Hazenberg, B.P.C.5
Lokhorst, H.M.6
Hammarström, P.7
ten Cate, H.8
de Groot, P.G.9
-
19
-
-
78149439563
-
Polyphosphate exerts differential effects on blood clotting, depending on polymer size
-
Smith SA, Choi SH, Davis-Harrison R, Huyck J, Boettcher J, Rienstra CM, Morrissey JH. Polyphosphate exerts differential effects on blood clotting, depending on polymer size. Blood 2010; 116: 4353-9.
-
(2010)
Blood
, vol.116
, pp. 4353-4359
-
-
Smith, S.A.1
Choi, S.H.2
Davis-Harrison, R.3
Huyck, J.4
Boettcher, J.5
Rienstra, C.M.6
Morrissey, J.H.7
-
20
-
-
0017149563
-
Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma
-
Mandle RJ, Colman RW, Kaplan AP. Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma. Proc Natl Acad Sci USA 1976; 73: 4179.
-
(1976)
Proc Natl Acad Sci USA
, vol.73
, pp. 4179
-
-
Mandle, R.J.1
Colman, R.W.2
Kaplan, A.P.3
-
21
-
-
0037085387
-
Characterization of the H-kininogen-binding site on factor XI: a comparison of factor XI and plasma prekallikrein
-
Renné T, Gailani D, Meijers JCM, Müller-Esterl W. Characterization of the H-kininogen-binding site on factor XI: a comparison of factor XI and plasma prekallikrein. J Biol Chem 2002; 277: 4892-9.
-
(2002)
J Biol Chem
, vol.277
, pp. 4892-4899
-
-
Renné, T.1
Gailani, D.2
Meijers, J.C.M.3
Müller-Esterl, W.4
-
22
-
-
78149237097
-
Combating innate inflammation: a new paradigm for acute treatment of stroke?
-
Stoll G, Kleinschnitz C, Nieswandt B. Combating innate inflammation: a new paradigm for acute treatment of stroke? Ann N Y Acad Sci 2010; 1207: 149-54.
-
(2010)
Ann N Y Acad Sci
, vol.1207
, pp. 149-154
-
-
Stoll, G.1
Kleinschnitz, C.2
Nieswandt, B.3
-
23
-
-
0030830360
-
Contact system: a vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes
-
Colman RW, Schmaier AH. Contact system: a vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes. Blood 1997; 90: 3819-43.
-
(1997)
Blood
, vol.90
, pp. 3819-3843
-
-
Colman, R.W.1
Schmaier, A.H.2
-
24
-
-
78149486483
-
Mechanisms by which cleaved kininogen inhibits endothelial cell differentiation and signalling
-
Colman RW, Wu Y, Liu Y. Mechanisms by which cleaved kininogen inhibits endothelial cell differentiation and signalling. Thromb Haemost 2010; 104: 875-85.
-
(2010)
Thromb Haemost
, vol.104
, pp. 875-885
-
-
Colman, R.W.1
Wu, Y.2
Liu, Y.3
-
25
-
-
79953738062
-
Cleaved high-molecular-weight kininogen accelerates the onset of endothelial progenitor cell senescence by induction of reactive oxygen species
-
Dai J, Zhu X, Yoder MC, Wu Y, Colman RW. Cleaved high-molecular-weight kininogen accelerates the onset of endothelial progenitor cell senescence by induction of reactive oxygen species. Arterioscler Thromb Vasc Biol 2011; 31: 883-9.
-
(2011)
Arterioscler Thromb Vasc Biol
, vol.31
, pp. 883-889
-
-
Dai, J.1
Zhu, X.2
Yoder, M.C.3
Wu, Y.4
Colman, R.W.5
-
26
-
-
79958133035
-
Interaction of high-molecular-weight kininogen with endothelial cell binding proteins suPAR, gC1qR and cytokeratin 1 determined by surface plasmon resonance (BiaCore)
-
Pixley RA, Espinola RG, Ghebrehiwet B, Joseph K, Kao A, Bdeir K, Cines DB, Colman RW. Interaction of high-molecular-weight kininogen with endothelial cell binding proteins suPAR, gC1qR and cytokeratin 1 determined by surface plasmon resonance (BiaCore). Thromb Haemost 2011; 105: 1053-9.
-
(2011)
Thromb Haemost
, vol.105
, pp. 1053-1059
-
-
Pixley, R.A.1
Espinola, R.G.2
Ghebrehiwet, B.3
Joseph, K.4
Kao, A.5
Bdeir, K.6
Cines, D.B.7
Colman, R.W.8
-
27
-
-
60549111207
-
Blockade of bradykinin receptor B1 but not bradykinin receptor B2 provides protection from cerebral infarction and brain edema
-
Austinat M, Braeuninger S, Pesquero JB, Brede M, Bader M, Stoll G, Renné T, Kleinschnitz C. Blockade of bradykinin receptor B1 but not bradykinin receptor B2 provides protection from cerebral infarction and brain edema. Stroke 2009; 40: 285-93.
-
(2009)
Stroke
, vol.40
, pp. 285-293
-
-
Austinat, M.1
Braeuninger, S.2
Pesquero, J.B.3
Brede, M.4
Bader, M.5
Stoll, G.6
Renné, T.7
Kleinschnitz, C.8
-
28
-
-
0036096015
-
Risk of arterial thrombosis in relation to oral contraceptives (RATIO) Study: oral contraceptives and the risk of ischemic stroke
-
Kemmeren JM, Tanis BC, van den Bosch MAAJ, Bollen ELEM, Helmerhorst FM, van der Graaf Y, Rosendaal FR, Algra A. Risk of arterial thrombosis in relation to oral contraceptives (RATIO) Study: oral contraceptives and the risk of ischemic stroke. Stroke 2002; 33: 1202-8.
-
(2002)
Stroke
, vol.33
, pp. 1202-1208
-
-
Kemmeren, J.M.1
Tanis, B.C.2
van den Bosch, M.A.A.J.3
Bollen, E.L.E.M.4
Helmerhorst, F.M.5
van der Graaf, Y.6
Rosendaal, F.R.7
Algra, A.8
-
29
-
-
0035924777
-
Oral contraceptives and the risk of myocardial infarction
-
Tanis BC, van den Bosch MA, Kemmeren JM, Cats VM, Helmerhorst FM, Algra A, van der Graaf Y, Rosendaal FR. Oral contraceptives and the risk of myocardial infarction. N Eng J Med 2001; 345: 1787-93.
-
(2001)
N Eng J Med
, vol.345
, pp. 1787-1793
-
-
Tanis, B.C.1
van den Bosch, M.A.2
Kemmeren, J.M.3
Cats, V.M.4
Helmerhorst, F.M.5
Algra, A.6
van der Graaf, Y.7
Rosendaal, F.R.8
-
30
-
-
0141928038
-
The RATIO study: oral contraceptives and the risk of peripheral arterial disease in young women
-
van den Bosch MA, Kemmeren JM, Tanis BC, Mali WPTM, Helmerhorst FM, Rosendaal FR, Algra A, van der Graaf Y. The RATIO study: oral contraceptives and the risk of peripheral arterial disease in young women. J Thromb Haemost 2003; 1: 439-44.
-
(2003)
J Thromb Haemost
, vol.1
, pp. 439-444
-
-
van den Bosch, M.A.1
Kemmeren, J.M.2
Tanis, B.C.3
Mali, W.P.T.M.4
Helmerhorst, F.M.5
Rosendaal, F.R.6
Algra, A.7
van der Graaf, Y.8
-
31
-
-
70449729881
-
Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study
-
Urbanus RT, Siegerink B, Roest M, Rosendaal FR, de Groot PG, Algra A. Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study. Lancet Neurol 2009; 8: 998-1005.
-
(2009)
Lancet Neurol
, vol.8
, pp. 998-1005
-
-
Urbanus, R.T.1
Siegerink, B.2
Roest, M.3
Rosendaal, F.R.4
de Groot, P.G.5
Algra, A.6
-
32
-
-
0028046383
-
Hemostatic abnormalities in acute myocardial infarction as detected by specific blood markers
-
Tanaka M, Suzuki A. Hemostatic abnormalities in acute myocardial infarction as detected by specific blood markers. Thromb Res 1994; 76: 289-98.
-
(1994)
Thromb Res
, vol.76
, pp. 289-298
-
-
Tanaka, M.1
Suzuki, A.2
-
33
-
-
0026437692
-
Coagulation, fibrinolytic, and inhibitory proteins in acute myocardial infarction and angina pectoris
-
Vaziri ND, Kennedy SC, Kennedy D, Gonzales E. Coagulation, fibrinolytic, and inhibitory proteins in acute myocardial infarction and angina pectoris. Am J Med 1992; 93: 651-7.
-
(1992)
Am J Med
, vol.93
, pp. 651-657
-
-
Vaziri, N.D.1
Kennedy, S.C.2
Kennedy, D.3
Gonzales, E.4
-
34
-
-
0027458015
-
The role of bradykinin in mediating ischemic brain edema in rats
-
Kamiya T, Katayama Y, Kashiwagi F, Terashi A. The role of bradykinin in mediating ischemic brain edema in rats. Stroke 1993; 24: 571-5.
-
(1993)
Stroke
, vol.24
, pp. 571-575
-
-
Kamiya, T.1
Katayama, Y.2
Kashiwagi, F.3
Terashi, A.4
-
35
-
-
0037110415
-
Activation of the tissue kallikrein-kinin system in stroke
-
Wagner S, Kalb P, Lukosava M, Hilgenfeldt U, Schwaninger M. Activation of the tissue kallikrein-kinin system in stroke. J Neurol Sci 2002; 202: 75-6.
-
(2002)
J Neurol Sci
, vol.202
, pp. 75-76
-
-
Wagner, S.1
Kalb, P.2
Lukosava, M.3
Hilgenfeldt, U.4
Schwaninger, M.5
|